a study on Prostate Cancer
RATIONALE: Eating a diet high in vegetables may slow down disease progression in patients with prostate cancer.
PURPOSE: This randomized clinical trial is studying how well diet works in altering disease progression in patients with prostate cancer on active surveillance.
The Men's Eating and Living (MEAL) Study: A Randomized Trial of Diet to Alter Disease Progression in Prostate Cancer Patients on Active Surveillance
CALGB 70807 is a randomized, phase III clinical trial designed to test this practical, diet-based intervention for prostate cancer in a broader clinical setting. Patients on AS will be randomized either to an intervention of centralized, telephone-based dietary counseling and structured dietary education or to a comparison control condition in which they receive the Prostate Cancer Foundation booklet. Study endpoints will include disease progression, incidence of treatment, and health-related quality of life.
OUTLINE: This is a multicenter study. Patients are stratified according to age (≤ 70 years vs> 70 years), race (black or african american vs other), and baseline prostate biopsy (0-12 months before registration vs> 12-24 months before registration). Patients are randomized to 1 of 2 treatment arms. Please see the arms section for more information.
Prostate Cancer stage I prostate cancer stage IIB prostate cancer stage IIA prostate cancer adenocarcinoma of the prostate
For males ages 50–80
Required Initial Laboratory Values:
© The Regents of the University of California